Manual Therapy on the Improvement of Functional Disability in Patients With Chronic Non Specific Low Back Pain
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background: Models have tried to explain the driving mechanisms behind chronic non specific low back pain (CNSLBP) in order to propose better appropriate conservative treatment. Altered responses at spinal and/or supraspinal level may affect the perception of pain and degree of disability of CNSLBP patients. Recent clinical recommendations still propose active exercises (AE) for CNSLBP. However, acceptance of exercises by patients may be limited by pain-related manifestations. Current evidences suggest manual therapy (MT) induces a short-term analgesic effect through neurophysiological mechanisms at peripheral, spinal and cortical levels. The aim of this study was first, to assess whether MT has an instant analgesic effect, and second, to compare the long-lasting effect on functional disability of MT followed by AE to sham therapy (ST) followed by AE. Methods: Forty-two CNSLBP patients without co-morbidities, randomly distributed into 2 treatment groups, received either spinal manipulation/mobilization (first intervention) plus AE (MT group; n = 22), or detuned ultrasound (first intervention) plus AE (ST group; n = 20). Eight therapeutic sessions were delivered over 4 to 8 weeks. Instant analgesic effect was obtained by measuring pain intensity (Visual Analogue Scale) before and immediately after the first intervention of each therapeutic session. Pain intensity, disability (Oswestry Disability Index) and fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire) were determined before treatment, after the 8th therapeutic session, and at 3- and 6-month follow-ups.
| Condition | Intervention |
|---|---|
|
Back Pain Lower Back Chronic |
Procedure: Manual therapy and active exercises Procedure: Detuned ultrasound and active exercises |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Manual Therapy Followed by Specific Active Exercises Versus a Placebo Followed by Specific Active Exercises on the Improvement of Functional Disability in Patients With Chronic Non Specific Low Back Pain: a Randomized Controlled Trial |
- Visual Analogue Scale - VAS-pain [ Time Frame: During treatment, over a period of 4 to 8 weeks ] [ Designated as safety issue: No ]self-report of clinical pain intensity, consisting of a 10 cm horizontal line scale on which is added the statements "no pain" on the left and "maximum intensity of pain" on the right
- Fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire - FABQ) [ Time Frame: Before randomization and untill 6 months after the end of treatment ] [ Designated as safety issue: No ]measures level of fear and avoidance beliefs about work and physical activity in patients with low back pain
| Enrollment: | 42 |
| Study Start Date: | December 2005 |
| Study Completion Date: | January 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Manual therapy and active exercises
Spinal manipulation /mobilisation
|
Procedure: Manual therapy and active exercises
Spinal manipulation/mobilisation (5-10 minutes), consisting of passive accessory intervertebral movements, muscle-energy techniques and high velocity, low amplitude dynamic thrust. Active exercises (20 minutes), consisting of mobility, stretching, strengthening and motor control exercises Other Names:
|
| Placebo Comparator: Detuned ultrasound and active exercises |
Procedure: Detuned ultrasound and active exercises
Electrotherapy device inactivated and ineffective. Active exercises, consisting of mobility, stretching, strengthening and motor control exercises
Other Name: Electrotherapy
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- suffering from non specific low back pain with or without symptoms in the lower extremity for a period between 12 and 26 weeks
- can maintain the usual medication
Exclusion Criteria:
- spinal fracture or surgery within the previous 6 months
- pregnancy
- neoplasia
- spinal infection
- spinal inflammatory arthritis
- low back pain of visceral origin
- severe sensitive and/or motor radicular deficit from nerve root origin of less than 6 months
- score of 3/5 or more on the Waddell Score
- on sick leaves from work for 6 months or more
- psychiatric disorders
- opioid medication
- patient unable to collaborate (linguistic barrier; cognitive impairments)
- radiologic abnormalities other than degenerative disease
- clinical neurogenic claudication.
Contacts and Locations| Switzerland | |
| Département de l'appareil locomoteur (DAL), Centre Hospitalier Universitaire Vaudois (CHUV) | |
| Lausanne, Vaud, Switzerland, 1005 | |
| Study Director: | Olivier Dériaz, MD, PhD | Institut de Recherche en Réadaptation et Clinique Romande de Réadaptation SUVACare, Sion, Switzerland |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Pierre Balthazard, Bachelor of sciences in physical therapy, University of Applied Sciences of Western Switzerland |
| ClinicalTrials.gov Identifier: | NCT01496144 History of Changes |
| Other Study ID Numbers: | FNS13DPD3-109903, FNS13DPD3-109903 |
| Study First Received: | December 16, 2011 |
| Last Updated: | December 20, 2011 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by University of Applied Sciences of Western Switzerland:
|
Chronic non specific low back pain Manual therapy Active exercises Pain Disability |
Additional relevant MeSH terms:
|
Back Pain Low Back Pain Pain |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013